ACAP1 is closely bound up with the level of immunocyte infiltration, immune regulators and chemokines, and has been used in the prediction of clinical outcomes with several tumors, including gynecologic tumors [41,42,43]. The gene discussed is ACAP1; the disease is female reproductive system neoplasm.